Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 12
2019 8
2020 20
2021 20
2022 27
2023 30
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
McDermott DF, Huseni MA, Atkins MB, Motzer RJ, Rini BI, Escudier B, Fong L, Joseph RW, Pal SK, Reeves JA, Sznol M, Hainsworth J, Rathmell WK, Stadler WM, Hutson T, Gore ME, Ravaud A, Bracarda S, Suárez C, Danielli R, Gruenwald V, Choueiri TK, Nickles D, Jhunjhunwala S, Piault-Louis E, Thobhani A, Qiu J, Chen DS, Hegde PS, Schiff C, Fine GD, Powles T. McDermott DF, et al. Nat Med. 2018 Jun;24(6):749-757. doi: 10.1038/s41591-018-0053-3. Epub 2018 Jun 4. Nat Med. 2018. PMID: 29867230 Free PMC article. Clinical Trial.
Escalating de-escalation in breast cancer treatment.
Sacchini V, Norton L. Sacchini V, et al. Breast Cancer Res Treat. 2022 Sep;195(2):85-90. doi: 10.1007/s10549-022-06685-2. Epub 2022 Jul 28. Breast Cancer Res Treat. 2022. PMID: 35902432
The treatment of aggressive prolactinomas with everolimus.
Lin AL, Geer EB, Lala N, Page-Wilson G, Magge R, Young RJ, Tabar V. Lin AL, et al. Pituitary. 2023 Aug;26(4):474-481. doi: 10.1007/s11102-023-01340-5. Epub 2023 Jul 10. Pituitary. 2023. PMID: 37428396 Review.
Insulin-Lowering Diets in Metastatic Cancer.
Shen S, Iyengar NM. Shen S, et al. Nutrients. 2022 Aug 27;14(17):3542. doi: 10.3390/nu14173542. Nutrients. 2022. PMID: 36079800 Free PMC article. Review.
Organ Preservation in Rectal Cancer.
Yuval JB, Thompson HM, Garcia-Aguilar J. Yuval JB, et al. J Gastrointest Surg. 2020 Aug;24(8):1880-1888. doi: 10.1007/s11605-020-04583-w. Epub 2020 Apr 20. J Gastrointest Surg. 2020. PMID: 32314234 Free PMC article. Review.
Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.
Kramer K, Pandit-Taskar N, Kushner BH, Zanzonico P, Humm JL, Tomlinson U, Donzelli M, Wolden SL, Haque S, Dunkel I, Souweidane MM, Greenfield JP, Tickoo S, Lewis JS, Lyashchenko SK, Carrasquillo JA, Chu B, Horan C, Larson SM, Cheung NV, Modak S. Kramer K, et al. J Hematol Oncol. 2022 Nov 12;15(1):165. doi: 10.1186/s13045-022-01383-4. J Hematol Oncol. 2022. PMID: 36371226 Free PMC article. Clinical Trial.
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions.
Schad SE, Chow A, Mangarin L, Pan H, Zhang J, Ceglia N, Caushi JX, Malandro N, Zappasodi R, Gigoux M, Hirschhorn D, Budhu S, Amisaki M, Arniella M, Redmond D, Chaft J, Forde PM, Gainor JF, Hellmann MD, Balachandran V, Shah S, Smith KN, Pardoll D, Elemento O, Wolchok JD, Merghoub T. Schad SE, et al. J Exp Med. 2022 Jun 6;219(6):e20212169. doi: 10.1084/jem.20212169. Epub 2022 May 23. J Exp Med. 2022. PMID: 35604411 Free PMC article.
128 results